Compare · GOOGL vs TEM
GOOGL vs TEM
Side-by-side comparison of Alphabet Inc. (GOOGL) and Tempus AI Inc. (TEM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GOOGL and TEM operate in Computer Software: Programming Data Processing (Technology), so they compete in similar markets.
- GOOGL is the larger of the two at $4.24T, about 493.1x TEM ($8.59B).
- Over the past year, GOOGL is up 110.4% and TEM is down 24.5% - GOOGL leads by 134.9 points.
- GOOGL has been more active in the news (37 items in the past 4 weeks vs 9 for TEM).
- Both have 25 recent analyst ratings on file.
- Company
- Alphabet Inc.
- Tempus AI Inc.
- Price
- $347.48-0.58%
- $49.54+3.45%
- Market cap
- $4.24T
- $8.59B
- 1M return
- -10.31%
- +6.55%
- 1Y return
- +110.43%
- -24.49%
- Industry
- Computer Software: Programming Data Processing
- Computer Software: Programming Data Processing
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2004
- 2024
- News (4w)
- 37
- 9
- Recent ratings
- 25
- 25
Alphabet Inc.
Alphabet Inc. provides online advertising services in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. The company offers performance and brand advertising services. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment provides products and services, such as ads, Android, Chrome, hardware, Google Maps, Google Play, Search, and YouTube, as well as technical infrastructure; and digital content. The Google Cloud segment offers infrastructure and data analytics platforms, collaboration tools, and other services for enterprise customers. The Other Bets segment sells internet and TV services, as well as licensing and research and development services. The company was founded in 1998 and is headquartered in Mountain View, California.
Latest GOOGL
- President, Global Affairs, CLO Walker John Kent was granted 94 units of Class C Google Stock Units, increasing direct ownership by 137% to 67,627 units (SEC Form 4)
- President and CIO Porat Ruth was granted 94 units of Class C Google Stock Units, increasing direct ownership by 137% to 67,627 units (SEC Form 4)
- VP, Chief Accounting Officer Saraci Marsida was granted 10 units of Class C Google Stock Units, decreasing direct ownership by 49% to 1,120 units (SEC Form 4)
- Director Hennessy John L. sold $387,063 worth of Class C Capital Stock (1,050 units at $368.63) as part of a pre-agreed trading plan and was granted 3 units of Class C Google Stock Units, increasing direct ownership by 2,106% to 2,226 units (SEC Form 4)
- Director Arnold Frances was granted 3 units of Class C Google Stock Units, increasing direct ownership by 1,825% to 1,558 units (SEC Form 4)
- SVP, Chief Financial Officer Ashkenazi Anat was granted 93 units of Class C Google Stock Units, increasing direct ownership by 180% to 69,585 units (SEC Form 4)
- SVP, Chief Business Officer Schindler Philipp was granted 119 units of Class C Google Stock Units, increasing direct ownership by 136% to 86,282 units (SEC Form 4)
- Chief Executive Officer Pichai Sundar was granted 137 units of Class C Google Stock Units, increasing direct ownership by 0.06% to 228,490 units (SEC Form 4)
- Director Chavez R. Martin was granted 3 units of Class C Google Stock Units, increasing direct ownership by 320% to 1,558 units (SEC Form 4)
- Director Ferguson Roger W. Jr. gave a grant of 1 units of Class C Google Stock Units and was granted 2 units of Class C Google Stock Units, increasing direct ownership by 1,825% to 1,558 units (SEC Form 4)
Latest TEM
- 16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap
- Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm
- Genetics in Medicine Open Study Demonstrates How Ambry Genetics' ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing
- Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
- Director Epstein David R sold $12,350 worth of shares (250 units at $49.40) as part of a pre-agreed trading plan, decreasing direct ownership by 0.79% to 31,464 units (SEC Form 4)
- Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members
- Wolfe Research resumed coverage on Tempus AI
- Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH
- Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development
- Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community